US Patent 7279579 Polymorphic forms of naltrexone
Patent 7279579 was granted and assigned to Alkermes on October, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+350 characters)
Article
Patent abstract
This invention relates to the discovery of novel polymorphic forms of naltrexone, including solvates, hydrates, anhydrous and other crystalline forms and combinations thereof. These novel forms of naltrexone impart advantages in pharmaceutical formulations incorporating them, including sustained release, or long acting, formulations.
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07279579 Polymorphic forms of naltrexone US Patent 7279579 Polymorphic forms of naltrexone
Infobox
Patent Number
0727957900
Patent Number
727957900
Edits on 27 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
0
Patent Jurisdiction
Patent Number
072795790
Date of Patent
October 9, 2007
0Patent Application Number
108606080
Date Filed
June 3, 2004
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
0
Patent Jurisdiction
Patent Number
072795790
Date of Patent
October 9, 2007
0Patent Application Number
108606080
Date Filed
June 3, 2004
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 22 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07279579 Polymorphic forms of naltrexone
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07279579
Date of patent
October 9, 2007
Patent application number
10860608
Date Filed
June 3, 2004
Patent primary examiner
Find more entities like US Patent 7279579 Polymorphic forms of naltrexone
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
